Skip to main content
SpringerLink
Log in

Lymphknotendissektion beim Nierenzellkarzinom

Lymph node dissection in patients with renal cell carcinoma

  • Leitthema
  • Published:
Der Urologe, Ausgabe A Aims and scope Submit manuscript

Zusammenfassung

Die Lymphknotendissektion bei Patienten mit Nierenzellkarzinom ist seit Jahrzehnten ein kontrovers diskutiertes Thema. Für die einzige prospektiv randomisierte Studie (EORTC 30881) liegt eine Endauswertung nicht vor. Retrospektive Analysen lassen sowohl diagnostisch als auch therapeutisch keinen Nutzen einer systematischen ausgiebigen Lymphknotendissektion vermuten. In der Bildgebung oder intraoperativ palpatorisch auffällige Lymphknoten sollten bei der Nephrektomie entfernt werden.

Abstract

The role of lymph node dissection in renal cell carcinoma has been controversial for decades. However, the results of the only prospective randomised study concerning this issue (EORTC 30881) are preliminary. Retrospective analyses were not able to demonstrate a diagnostic or therapeutic benefit of an extended lymph node dissection. Suspicious lymph nodes (imaging, palpation) should be excised during nephrectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. American College of Radiology (1995) ACR Appropriateness Criteria: Renal cell carcinoma staging. American College of Radiology — Medical Specialty Society. 1995 (revised 2001). NGC: 002498http://www.guideline.com

  2. Blom JHM, van Poppel H, Marechal JM, Jacqmin D, Sylvester R, Schroeder FH, de Prijck L (1999) Radical nephrectomy with and without lymph node dissection: preliminary results of EORTC randomized phase III protocol 30881. Eur Urol 36: 570–575

    Article  CAS  PubMed  Google Scholar 

  3. Blute ML, Leibovich BC, Cheville JC, Lohse CM, Zincke H (2004) A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma. J Urol 172: 465–469

    Article  PubMed  Google Scholar 

  4. Fisher ER, Swamidoss S, Lee CH, Rockette H, Redmond C, Fisher B(1978) Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer 42: 2025–2031

    CAS  PubMed  Google Scholar 

  5. Golimbu M, Joshi P, SperberA, Tessler A, Al-Askari S, Morales P (1986) Renal cell carcinoma: survival and prognostic factors. Urology 27: 291–301

    Article  CAS  PubMed  Google Scholar 

  6. Herrlinger A, Schrott KM, Schott G, Sigel A (1991) What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma? J Urol 146: 1224–1227

    CAS  PubMed  Google Scholar 

  7. Hultén L, Rosenkrantz T, Seeman L, Wahlquist L, Ahren C (1969) Occurrence and localisation of lymph node metastases in renal cell carcinoma. A lymphographic and histopathological investigation in connection with nephrectomy. Scand J Urol Nephrol 3: 129–130

    PubMed  Google Scholar 

  8. Johnsen JA, Hellsten S (1997) Lymphatogenous spread of renal cell carcinoma: an autopsy study. J Urol157: 450–453

  9. Minervini A, Lilas L, Morelli G, Traversi C, Battaglia S, Cristofani R, Minervini R (2001) Regional lymph node dissection in the treatment of renal cell carcinoma: is it useful in patients with no suspected adenopathy before or during surgery? BJU Int 88: 169-172

    Article  CAS  PubMed  Google Scholar 

  10. Pantuck AJ, Zisman A, Dorey F, Chao DH, Han K, Said J, Belldegrun AS, Figlin RA (2003) Renal cell carcinoma with retroperitoneal lymph nodes. Cancer 97: 2995–3002

    Article  PubMed  Google Scholar 

  11. Parker AE (1935) Studies on the main posterior lymph channels of the abdomen and their connections with the lymphatics of the genitor-urinary system. Am J Anat 56: 409–442

    Article  Google Scholar 

  12. Peters P, Brown GL (1980) The role of lymphadenectomy in the management of renal cell carcinoma. Urol Clin North Am 7: 705–709

    CAS  PubMed  Google Scholar 

  13. Saitoh H, Nakayama M, Nakamura K, Satoh T (1982) Distant metastases of renal adenocarcinoma in nephrectomized cases. J Urol 127: 1092–1095

    CAS  PubMed  Google Scholar 

  14. Studer UE, Scherz S, Scheidegger J, Kraft R, Sonntag R, Ackermann D, Zingg EJ (1990) Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol 144: 243–245

    CAS  PubMed  Google Scholar 

  15. Terrone C, Guercio S, De Luca S et al. (2003) The number of lymph nodes examined and staging accuracy in renal cell carcinoma. BJU Int 91: 37–40

    Article  CAS  PubMed  Google Scholar 

Download references

Interessenkonflikt:

Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.

Author information

Authors and Affiliations

  1. Urologische Belegabteilung, EuromedClinic, Fürth

    T. Ebert & L. Weißbach

  2. Sanitätsamt Bw, München

    D. Schnell

  3. Urologische Belegabteilung, EuromedClinic, Europa-Allee 1, 90763, Fürth

    T. Ebert

Authors
  1. T. Ebert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Schnell
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Weißbach
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. Ebert.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ebert, T., Schnell, D. & Weißbach, L. Lymphknotendissektion beim Nierenzellkarzinom. Urologe [A] 44, 635–637 (2005). https://doi.org/10.1007/s00120-005-0829-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-005-0829-1

Schlüsselwörter

Keywords

Search

Navigation